1. James, a 3-year-old, has been diagnosed with acute lymphoblastic leukemia and will begin receiving chemotherapy with the mitotic inhibitor teniposide (Vumon) and the alkylating agent cyclophosphamide (Cytoxan) in the morning.
a. . What special considerations are needed for a child James’ age who will receive chemotherapy?
2. Ms. Smith will be receiving chemotherapy for advanced breast cancer. She is 75 years old and resides in a long-term care facility. Her treatment plan will include the use of the hormone goserelin (Zoladex) and capecitabine (Xeloda), which is an antimetabolite.
a. What special monitoring might Ms. Smith require during her treatment?
b. What adjustments to Ms. Smith’s living arrangements might be required?